Israel - English - Ministry of Health

neopharm scientific ltd - romidepsin - powder and diluent for solution for injection - romidepsin 10 mg/vial - romidepsin - romidepsin - • treatment of cutaneous t-cell lymphoma (ctcl) in patients who have received at least one prior systemic therapy.• treatment of peripheral t-cell lymphoma (ptcl) in patients who have received at least one prior therapy.

European Union - English - EMA (European Medicines Agency)

celgene europe ltd. - romidepsin - lymphoma, non-hodgkin - antineoplastic agents - treatment of peripheral t-cell lymphoma (ptcl),

Israel - English - Ministry of Health

teva israel ltd - romidepsin - solution for injection - romidepsin 5 mg/ml - romidepsin - romidepsin teva is indicated for the:- treatment of cutaneous t-cell lymphoma (ctcl) in patients who have received at least one prior systemic therapy. - treatment of peripheral t-cell lymphoma (ptcl) in patients who have received at least one prior therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

romidepsin -

Australia - English - Department of Health (Therapeutic Goods Administration)

reach pharmaceuticals pty ltd - romidepsin, quantity: 10 mg - diluent, not applicable - excipient ingredients: propylene glycol; ethanol absolute - romidepsin-reach is indicated for the treatment of peripheral t-cell lymphoma in patients who have received at least one prior systemic therapy.